|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Current | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Other receivables | |||||||||||||||||||
| Prepaid and deposit | |||||||||||||||||||
| Current assets | |||||||||||||||||||
| Other Receivables - long term | |||||||||||||||||||
| Non-Current | |||||||||||||||||||
| Mineral properties | |||||||||||||||||||
| Reclamation bonds | |||||||||||||||||||
| Investment in associate | |||||||||||||||||||
| Right of use asset | |||||||||||||||||||
| Investment other | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Property and equipment | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities and Equity | |||||||||||||||||||
| LIABILITIES | |||||||||||||||||||
| Current | |||||||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||||||
| Accrued liabilities | |||||||||||||||||||
| Nuton LLC earn in liability | |||||||||||||||||||
| SAFE Notes | |||||||||||||||||||
| Convertible debentures | |||||||||||||||||||
| Derivative liabilities | |||||||||||||||||||
| Lease liability | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Convertible debentures - long term | |||||||||||||||||||
| Lease liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Shareholders' Equity | |||||||||||||||||||
| Share capital, no par value, unlimited common shares authorized; 431,222,956 issued and outstanding (December 31, 2025 - 413,234,899) | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Commitment to issue shares | |||||||||||||||||||
| Deficit | |||||||||||||||||||
| Non-controlling interest | |||||||||||||||||||
| Total shareholders' equity | |||||||||||||||||||
| Total liabilities and shareholders' equity | |||||||||||||||||||
Loading...